INCY
Incyte Corporation · Healthcare · Biotechnology
TECHSellZACKSHold
R500#456 today
$115.30
-1.57% today · -6.93% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- INCY −1.57% on the last session vs SPY +0.74%: −2.3 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 64 big drops in the past 5 years, INCY typically gained 0.7% over the next week (median) and was higher 56% of the time; half the outcomes fell between -1.7% and +2.4%. An ordinary week: +0.1%. Among S&P 500 stocks after big drops, that ranks #128 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $23.4B
- Held by institutions
- 103.4%
- Short interest
- 8.4%
- 52-week range
- 82.82–132.60
- Analyst mean target
- —
- Next earnings
- Oct 27 est.
- Forward P/E
- 13.0
Recent events
Earnings ▲
2Q2026 results: EPS $3.09 vs $2.15 expected beat +$0.94 (+43.9%); revenue $1.7B; next session +9.3% (+9.1 vs SPY)Earnings ▲
1Q2026 results: EPS $1.81 vs $1.34 expected beat +$0.47 (+35.1%); revenue $1.3B; next session +2.1% (+2.6 vs SPY)Earnings ▼
4Q2025 results: EPS $1.80 vs $1.92 expected miss −$0.12 (−6.1%); revenue $1.5B; next session -8.2% (-8.0 vs SPY)Earnings ▲
3Q2025 results: EPS $2.26 vs $1.64 expected beat +$0.62 (+38.0%); revenue $1.4B; next session -1.5% (-1.8 vs SPY)